Roche fully acquires privately-owned biotech company Piramed
Roche announced that it will acquire Piramed Limited, a privately-owned UK company focusing on therapeutics targeting PI3-kinase (PI3-K). The PI3-K pathway is known to play an important role in disease progression and in resistance to chemotherapeutics in cancer cells.
Read more ...
Patients with early Parkinson's disease show better symptom control
A new study in patients with early Parkinson's disease demonstrates that Stalevo® (levodopa/carbidopa/entacapone) gives better symptom control[1] and greater improvements in activities of daily living[1] than levodopa/carbidopa, the most widely-used current therapy.
Read more ...
AstraZeneca Settles US Nexium Patent Litigation with Ranbaxy
AstraZeneca today announced it has entered into a settlement agreement in its Nexium patent infringement litigation against Ranbaxy Laboratories Ltd. and its affiliates ("Ranbaxy").
Read more ...
Dr. Reddy's acquires Jet Generici Srl. Acquisition to establish Generics business in Italy
Dr. Reddy's Laboratories Ltd (NYSE:RDY) announced that it has acquired Jet Generici Srl, a company engaged in the sale of generic finished dosages in Italy. The deal has been completed via Dr Reddy's Italian subsidiary, Reddy Pharma Italia SpA, which has been engaged in building a pipeline of registrations since its incorporation.
Read more ...
The first vaccine licensed to complete the rotavirus immunisation series by four months of age
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants. Rotarix will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age.
Read more ...
International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM)
Clinical laboratory professionals worldwide are coming together in support of an initiative to raise international awareness of the role played by clinical laboratory professionals in health care and their vital contribution to improve patient outcomes. Through a program called Labs Are Vital(TM), sponsored by Abbott (NYSE: ABT), the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and its 76 national societies are working together to elevate the role of laboratory professionals and to address issues facing the profession globally.
Read more ...